Sidetrade reported Q2 2026 bookings growth of €3.11M new ARR (+168% YoY) and €5.6M ACV (+80% YoY), alongside services bookings of €2.49M (+28% YoY). In H1 2026, new ARR reached €5.16M (+112% YoY) and ACV rose to €9.3M (+58% YoY), with TCV up to €18.71M (+194% YoY). AI-native products contributed >€1.0M ARR in their first three months (33% of total H1 ARR bookings), with 80 AI agents ordered in Q2 alone, and management states H1 bookings already exceed full-year 2025 by 20%.
This is more than a good print; it is evidence that a narrow class of software vendors can monetize AI when they own the workflow, the data, and the inference stack. The second-order winner is not just the application layer but the infrastructure that sits behind private deployment: NVDA should continue to capture demand from enterprise-grade H100/H200 installs even when customers refuse hyperscaler-hosted tokens. By contrast, the message is mildly negative for cloud-first AI vendors whose value prop depends on consumption-based model access; once buyers see a credible private alternative with predictable unit economics, pricing power shifts away from generic model wrappers.
The competitive implication is that vertical software with proprietary data and hard compliance constraints may widen its moat versus horizontal SaaS that is merely "AI-enabled." That favors a small subset of vendors in finance ops, collections, and adjacent enterprise automation, while increasing pressure on incumbents that cannot prove measurable ROI. The Hackett validation angle matters because it lowers perceived implementation risk for large enterprises; that can accelerate procurement cycles over the next 1-3 quarters, but the structural effect is 6-18 months: higher switching costs, longer contract duration, and potentially higher gross margins if AI modules scale faster than services.
The main risk is extrapolation. Microcap growth names can gap on one strong half-year and then mean-revert if deployments slip from pre-booking to revenue conversion, especially with production rollout deferred to Q4. What would falsify the thesis is any sign that the AI-native mix stalls below management’s implied trajectory or that new bookings normalize after launch novelty fades. The contrarian view is that the market may already be rewarding the "AI-native" label without proof that the incremental ARR is durable or that token economics stay attractive once usage scales; if customer cohorts churn or implementation time lengthens, the premium should compress quickly.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.78
Ticker Sentiment